661 related articles for article (PubMed ID: 33219199)
1. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
3. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
[TBL] [Abstract][Full Text] [Related]
4. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
Lai J; Yang H; Xu T
BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular Carcinoma.
Liu Z; Ye J; Khan AA; Chen J; Zhou L; Zheng S; Xu X
Med Sci Monit; 2021 Aug; 27():e930052. PubMed ID: 34407065
[TBL] [Abstract][Full Text] [Related]
6. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.
Duan Y; Zhang D
J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370
[TBL] [Abstract][Full Text] [Related]
8. Novel insights into clear cell renal cell carcinoma prognosis by comprehensive characterization of aberrant alternative splicing signature: a study based on large-scale sequencing data.
Zhang D; Zhang W; Sun R; Huang Z
Bioengineered; 2021 Dec; 12(1):1091-1110. PubMed ID: 33783315
[TBL] [Abstract][Full Text] [Related]
9. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract][Full Text] [Related]
10. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
Wan Q; Sang X; Jin L; Wang Z
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
Front Immunol; 2021; 12():719628. PubMed ID: 34413861
[TBL] [Abstract][Full Text] [Related]
12. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
13. Role of alternative splicing signatures in the prognosis of glioblastoma.
Xie ZC; Wu HY; Dang YW; Chen G
Cancer Med; 2019 Dec; 8(18):7623-7636. PubMed ID: 31674730
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Alternative mRNA Splicing in Adrenocortical Carcinoma.
Liang W; Sun F
Front Endocrinol (Lausanne); 2021; 12():538364. PubMed ID: 33776902
[TBL] [Abstract][Full Text] [Related]
15. Characterization of alternative splicing events and prognostic signatures in breast cancer.
Han P; Zhu J; Feng G; Wang Z; Ding Y
BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
[TBL] [Abstract][Full Text] [Related]
16. Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.
Zhao J; Chang L; Gu X; Liu J; Sun B; Wei X
Cancer Sci; 2020 Aug; 111(8):3020-3031. PubMed ID: 32530556
[TBL] [Abstract][Full Text] [Related]
17. The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer.
Lou S; Zhang J; Zhai Z; Yin X; Wang Y; Fang T; Xue Y
Aging (Albany NY); 2021 Jan; 13(3):4317-4334. PubMed ID: 33428603
[TBL] [Abstract][Full Text] [Related]
18. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
Chang YS; Tu SJ; Chiang HS; Yen JC; Lee YT; Fang HY; Chang JG
Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33142748
[TBL] [Abstract][Full Text] [Related]
19. A Robust Circular RNA-Associated Three-Gene Prognostic Signature for Patients with Gastric Cancer.
Li Y; Li R; Wang X; Yuan Y; Zhang Y
Biomed Res Int; 2021; 2021():6633289. PubMed ID: 33969120
[TBL] [Abstract][Full Text] [Related]
20. A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.
Zhao E; Zhou C; Chen S
Clin Transl Oncol; 2021 Feb; 23(2):265-274. PubMed ID: 32519178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
